Table 4.
Baseline | 12 month follow-up | |||||
---|---|---|---|---|---|---|
Control (n=237) | Intervention (n=221) | Control (n=192) | Intervention (n=179) | P* | ||
Total cholesterol (mg/dL; 1 mg/dL=0.026 mmol/L) | 282.0 (274.8 to 289.1) | 281.3 (272.9 to 289.7) | 266.5 (259.1 to 273.8) | 243.9 (237.4 to 250.4) | <0.001 | |
Triglycerides (mg/dL; 1 mg/dL=0.011 mmol/L) | 185.9 (168.8 to 202.9) | 189.0 (162.6 to 215.4) | 151.8 (133.9 to 169.7) | 135.5 (126.0 to 145.1) | 0.06 | |
Body mass index | 25.4 (25.1 to 25.8) | 25.1 (24.8 to 25.3) | 24.5 (24.1 to 24.9) | 24.3 (24.0 to 24.6) | 0.26 | |
Systolic blood pressure (mm Hg) | 136.9 (134.2 to 139.6) | 136.6 (133.9 to 139.3) | 136.5 (133.4 to 139.5) | 136.4 (133.8 to 139.0) | 0.49 | |
Diastolic blood pressure (mm Hg) | 88.5 (86.9 to 90.0) | 88.5 (86.9 to 90.2) | 87.9 (86.0 to 89.9) | 87.5 (85.7 to 89.3) | 0.38 |
Data are mean (95% confidence interval) at baseline and 12 months after randomization.
*P values=between group differences, assessed by t test.